Abiomed wins CE Mark for Impella RP heart pump

Abiomed says it won CE Mark approval in the European Union for its Impella RP right-side heart pump.

Abiomed (NSDQ:ABMD) said it won CE Mark approval in the European Union for its Impella RP heart pump, designed to assist the heart's right ventricle in heart failure patients.

Abiomed Inc.

News Well, Cardiac Assist Devices, CE Mark, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kGuXSC